Breaking News Instant updates and real-time market news.

CHK

Chesapeake

$6.65

-0.15 (-2.21%)

, GM

General Motors

$32.53

-0.15 (-0.46%)

07:35
10/07/16
10/07
07:35
10/07/16
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Thursday in Chesapeake Energy (CHK), General Motors (GM), Whiting (WLL), Whole Foods Market (WFM), MetLife (MET), HCA (HCA), Smith and Wesson (SWHC), and Comerica (CMA).

CHK

Chesapeake

$6.65

-0.15 (-2.21%)

GM

General Motors

$32.53

-0.15 (-0.46%)

WLL

Whiting Petroleum

$9.09

0.19 (2.13%)

WFM

Whole Foods

$29.33

1.37 (4.90%)

MET

MetLife

$47.15

1.16 (2.52%)

HCA

HCA Holdings

$74.60

-0.14 (-0.19%)

SWHC

Changed to AOBC

$25.21

-0.95 (-3.63%)

CMA

Comerica

$49.20

-0.01 (-0.02%)

  • 18

    Oct

  • 25

    Oct

  • 03

    Nov

  • 06

    Nov

CHK Chesapeake
$6.65

-0.15 (-2.21%)

08/16/16
08/16/16
UPGRADE

On The Fly: Top analyst upgrades
Catch up on today's top analyst upgrades with this list compiled by The Fly: 1. Vipshop (VIPS) was upgraded to Buy from Neutral at BofA/Merrill. 2. Chesapeake (CHK) was upgraded to Equalweight from Underweight and Forum Energy (FET) was upgraded to Overweight from Equalweight at Capital One. 3. Noble Corp. (NE) and Patterson-UTI (PTEN) were upgraded to Neutral from Underperform while Marathon Oil (MRO) and Sasol (SSL) were upgraded to Buy from Neutral at BofA/Merrill. 4. Shenandoah (SHEN) was upgraded to Outperform from Market Perform at Raymond James with analyst Ric Prentiss citing valuation, increased visibility into the future of the combined nTelos (NTLS) and Sprint (S) entity, and expectations of further transactions with Sprint that would expand its wireless coverage footprint and serve as a further catalysts for shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/09/16
WDLK
09/09/16
UPGRADE
Target $10
WDLK
Buy
Chesapeake upgraded to Buy from Hold at Wunderlich
Wunderlich analyst Jason Wangler upgraded Chesapeake Energy to Buy saying the company's assets are performing and its balance sheet is improving. The analyst raised his price target for the shares to $10 from $6.
09/09/16
09/09/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Chesapeake (CHK) upgraded to Buy from Hold at Wunderlich with analyst Jason Wangler saying the company's assets are performing and its balance sheet is improving. 2. GameStop (GME) upgraded to Buy from Neutral at Hilliard Lyons. 3. Finisar (FNSR) upgraded to Buy from Neutral at MKM Partners with analyst Michael Genovese saying he is "extremely upbeat on the Optical components/module industry," and Chinese demand for 10G and 100G Optical modules appears it can stay strong for multiple years. 4. Randgold (GOLD) upgraded to Buy from Neutral at UBS with the firm citing the recent pullback in the shares and the potential for a dividend raise in 2017. 5. Teekay LNG (TGP) upgraded to Outperform from Market Perform at Wells Fargo analyst Michael Webber saying the discount to net asset value and the company's progress around financing its order book make the valuation "particularly compelling." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/16
FBRC
09/13/16
INITIATION
Target $5
FBRC
Underperform
Chesapeake initiated with an Underperform at FBR Capital
FBR Capital analyst Joseph Allman started Chesapeake Energy with an Underperform rating and $5 price target. The company's "debt and transportation commitments hole still appears too deep to dig out of," Allman tells investors in a research note. He views Chesapeake's equity as "significantly overvalued" and thinks the company's financial condition "will continue to be stressed."
GM General Motors
$32.53

-0.15 (-0.46%)

09/19/16
09/19/16
UPGRADE
Target $37

Overweight
General Motors upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley upgraded General Motors to Overweight from Equal Weight and increased its price target to $37 from $29. Analyst Adam Jonas raised near-term earnings estimates 5% above consensus and believes even flat earnings in 2017 and 2018 would be received as a positive surprise by the market. Further, the analyst said investors are underestimating how long the auto cycle can last and that General Motor's earnings and free cash flow could have a materially longer duration than the market is currently discounting. He believes investors are overlooking the time and steps needed for fully autonomous transport and said management has a healthy and realistic acceptance that it can't and should not do everything alone and will likely explore new business structures with the potential of positive values.
09/19/16
09/19/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying he believes even flat earnings in 2017 and 2018 would be received as a positive surprise by the market. 2. Wells Fargo (WFC) upgraded to Outperform from Neutral at Baird analyst David George saying he believes the recent pullback is a buying opportunity. 3. Lockheed Martin (LMT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Sam Pearlstein saying he believes the company's earnings can grow 20% per year through 2020. 4. U.S. Steel (X), AK Steel (AKS), and Olympic Steel (ZEUS) were upgraded to Sector Weight from Underweight at KeyBanc with analyst Ivan Marcuse saying the stocks at current levels better reflect the more competitive market conditions he expects in Q4 and 2017. 5. Mattel (MAT) upgraded to Buy from Neutral at Monness Crespi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
GSCO
10/06/16
NO CHANGE
GSCO
Autos and Autos Parts sector downgraded to Cautious from Neutral at Goldman
Goldman analyst David Tamberrino downgraded the Autos and Auto Parts sector to Cautious from Neutral saying the US Auto cycle peaked in 2015 and is being held up by increasing OEM incentives. The analyst said OEM earnings will decline in 2017/2018 as negative pricing and lower production pressure North American results, but expects suppliers' earnings to hold up longer. The analyst sees upside to Delphi (DLPH) and Harman (HAR) given exposure to secular growth areas and upside to Goodyear Tire (GT) given secular HVA tire growth. Tamberrino downgraded Lear (LEA) to Sell citing elevated expectations and valuation, cut BorgWarner (BWA) to Neutral on valuation, downgraded Tesla (TSLA) to Neutral on execution risk and capital deployment, and upgraded AutoNation (AN) to Neutral given a more defensive business.
09/20/16
NOMU
09/20/16
INITIATION
Target $33
NOMU
Neutral
General Motors initiated with a Neutral at Nomura
Nomura analyst Anindya Das initiated General Motors with a Neutral and a $33 price target. The analyst said General Motors has significant exposure to the Chinese auto market and is concerned about pricing pressures in the market. Further, the company has yet to break even in Europe on an annual basis and its near-term prospects are clouded by Brexit uncertainties.
WLL Whiting Petroleum
$9.09

0.19 (2.13%)

09/13/16
FBRC
09/13/16
INITIATION
Target $8
FBRC
Market Perform
Whiting Petroleum initiated with a Market Perform at FBR Capital
FBR Capital analyst Joseph Allman started Whiting Petroleum with a Market Perform rating and $8 price target.
07/12/16
GHSC
07/12/16
UPGRADE
Target $8
GHSC
Neutral
Whiting Petroleum upgraded to Neutral from Sell at Seaport Global
07/13/16
FBCO
07/13/16
UPGRADE
Target $14
FBCO
Outperform
Whiting Petroleum upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analysts led by Mark Lear upgraded Whiting Petroleum to Outperform following the pullback in shares following the recently announced debt swap. The analyst raised Whiting's price target to $14 from $13.
10/05/16
MZHO
10/05/16
INITIATION
Target $9
MZHO
Neutral
Whiting Petroleum initiated with a Neutral at Mizuho
Mizuho analyst Timothy Rezvan initiated Whiting Petroleum with a Neutral and a $9 price target.
WFM Whole Foods
$29.33

1.37 (4.90%)

09/23/16
LEHM
09/23/16
INITIATION
Target $30
LEHM
Equal Weight
Whole Foods initiated with an Equal Weight at Barclays
Barclays analyst Karen Short started Whole Foods Market with an Equal Weight rating and $30 price target.
08/04/16
FBCO
08/04/16
NO CHANGE
Target $40
FBCO
Outperform
Whole Foods added to US Focus List at Credit Suisse
07/26/16
07/26/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) and Time Warner (TWX) downgraded to Market Perform from Outperform at FBR Capital with analyst Barton Crocket saying Disney's stock "will struggle to deliver much upside" from current levels. The analyst lowered his price target for the shares to $108 from $111. The analyst downgraded Time Warner citing valuation. 2. Chipotle (CMG) downgraded to Sell from Hold at Stifel with analyst Paul Westra citing the firm's belief that the U.S. economy will probably enter a recession within nine months. 3. Whole Foods (WFM) downgraded to Sell from Neutral at Goldman with analyst Stephen Tanal saying Whole Foods is losing share in its core natural and organic business to a variety of competitors that have raised the bar and driven a consistent deceleration in Whole Foods' same-store-sales and its first negative comps in the fourth quarter of 2016 since 2009. 4. BJ's Restaurants (BJRI) downgraded to Sell from Buy at Stifel with analyst Paul Westra citing the firm's belief that the U.S. economy will probably enter a recession within nine months. 5. Yahoo (YHOO) downgraded to Equal Weight from Overweight at Morgan Stanley with analysts led by Brian Nowak saying shares going forward will solely be viewed as a trading vehicle for its 15% Alibaba (BABA) stake with the investment thesis related to shares closing the estimated 39% liquidity discount to fair market value. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/07/16
SBSH
10/07/16
NO CHANGE
Target $39
SBSH
Buy
Citi says Whole Foods buyout would be uncharacteristic for Kroger
Citi analyst Alvin Concepcion weighs in on the speculation yesterday that Kroger (KR) could be interested in acquiring Whole Foods (WFM) for $40 per share. There are challenges that reduce the likelihood of a deal, and such a transaction could be uncharacteristic for Kroger, Concepcion tells investors in a research note. For one, the acquisition would be expensive, the analyst contends. And two, Kroger would have to lever up to 3.5 times net debt/EBITDA, he adds. The analyst keeps a Buy rating on Kroger with a $39 price target. Whole Foods yesterday closed up 5% to $29.33 amid the takeout rumor.
MET MetLife
$47.15

1.16 (2.52%)

09/23/16
WELS
09/23/16
INITIATION
WELS
Outperform
MetLife coverage resumed at Wells Fargo
As noted earlier, Wells Fargo resumed coverage of MetLife with an Outperform rating. The firm says that , in the wake of the company's decision to separate its retail business, it "should be less impacted by equity market movement and interest rates." As a result, the firm thinks that the stock's multiple should rise, while the company should require less capital, enabling it to buy back its shares. Wells set a $51-$53 price target on the stock.
09/22/16
WELS
09/22/16
INITIATION
WELS
Outperform
MetLife coverage resumed with an Outperform at Wells Fargo
10/07/16
FBCO
10/07/16
INITIATION
Target $51
FBCO
Neutral
MetLife initiated with a Neutral at Credit Suisse
Credit Suisse analyst John Nadel initiated MetLife with a Neutral and a $51 price target.
07/13/16
07/13/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Underperform from Market Perform at Wells Fargo with analyst Peter Stabler saying consensus expectations "embed too much optimism" for 2017 and 2018. 2. Starbucks (SBUX) downgraded to Mixed from Positive at OTR Global with the firm citing manager checks that indicate weaker-than-expected food and Frappuccino sales, impact from poor weather, and cannibalization. 3. SQM (SQM) downgraded to Sell from Neutral at Citi analyst Juan Tavarez saying the risk/reward is unfavorable with the stock up 42% year-to-date. 4. Robert Half (RHI) downgraded to Neutral from Buy at BofA/Merrill with the firm citing expectations of weaker fundamentals, FX headwinds, and increased concerns around the timing of the cycle. 5. MetLife (MET) downgraded to Hold from Buy at Deutsche Bank with analyst Yaron Kinar saying balance sheet risk is enhanced ahead of the company's separation and in light of low yields. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
HCA HCA Holdings
$74.60

-0.14 (-0.19%)

04/13/16
OPCO
04/13/16
NO CHANGE
OPCO
Oppenheimer remains a long-term buyer of hospital group
Oppenheimer analyst Michael Wiederhorn remains a long-term buyer of hospitals, given the overrated risks to the group, the potential for additional Affordable Care Act growth and attractive valuations. The analyst's favorite name continues to be blue-chip HCA Holdings (HCA), which is still outperforming operationally. Additionally, Wiederhorn views Community Health (CYH) as a high-risk, high-reward name, with "high upside potential."
07/29/16
JPMS
07/29/16
DOWNGRADE
Target $85
JPMS
Neutral
HCA Holdings downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Gary Taylor downgraded HCA Holdings to Neutral saying the company's weaker than expected revenue and patient volume growth has not produced the leverage nor EBITDA growth he anticipated. The analyst keeps an $85 price target for the shares following the company's Q2 results.
06/16/16
06/16/16
INITIATION

Bernstein initiates coverage of U.S. healthcare services, upbeat on MCOs
Bernstein says that managed care organizations, or MCOs, will become more powerful as cost control increases in importance. The firm thinks that vendors, including pharmacy benefit managers, will be "squeezed" by MCOs as cost control becomes increasingly important. The firm adds that MCOs are also benefiting from acquisitions and pharmacy benefit management insourcing. It identifies MCOs Anthem (ANTM), UnitedHealth (UNH) and Aetna (AET) as its top picks, and started all three stocks with Outperform ratings. The firm initiated MCO Centene (CNC) and hospital owner HCA Holdings (HCA) with Market Perform ratings, and it started coverage of PBM Express Scripts (ESRX) with an Underperform rating.
05/04/16
OPCO
05/04/16
NO CHANGE
Target $95
OPCO
Outperform
HCA Holdings price target raised to $95 from $85 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for HCA Holdings to $95 from $85 on valuation. The analyst says the company's Q1 was "fairly close to expectations" and that any weakness would represent a "good" buying opportunity. Wiederhorn reiterates an Outperform rating on the shares.
SWHC Changed to AOBC
$25.21

-0.95 (-3.63%)

09/26/16
COWN
09/26/16
NO CHANGE
Target $34
COWN
Outperform
Smith & Wesson potential selection by Army not included in guidance, says Cowen
Cowen analyst Cai von Rumohr said it was surprising that Smith & Wesson was not selected by the Army to compete in the testing phase of the Modular Handgun System, or MHS, project, but also noted that MHS was not included in the company's guidance. The analyst, who thinks S&W shares still look cheap, keeps an Outperform rating on the gunmaker's stock, which is down over 4% to $26.40 in pre-market trading.
10/06/16
WDLK
10/06/16
DOWNGRADE
Target $29
WDLK
Hold
Smith & Wesson downgraded to Hold from Buy at Wunderlich
Wunderlich analyst Rommel Dionisio downgraded Smith & Wesson to Hold and lowered his price target for the shares to $29 from $36 citing decelerating industry demand.
09/02/16
CHLM
09/02/16
DOWNGRADE
Target $33
CHLM
Hold
Smith & Wesson downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Steven Dyer downgraded Smith & Wesson to Hold from Buy, as he thinks the current environment is "as good as it gets" for firearms demand. Based on past cycles, Dyer contends that November's election and activity right after that will likely mark the top of the current firearms cycle and the stock will react as comps become more difficult. Dyer lowered his price target on Smith & Wesson shares to $33 from $35.
09/02/16
09/02/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Carnival (CCL) downgraded to Underweight from Equal Weight at Morgan Stanley by analyst Jamie Rollo after the firm's checks indicated cruise demand weakened and prices were soft in August. The analyst lowered Carnival's price target to $48 from $54. 2. lululemon (LULU) downgraded to Equal Weight from Overweight by Morgan Stanley analyst Kimberly Greenberger following the company's earnings report. She noted that the company's comps are decelerating and that traffic remains a headwind. Given the slowdown seen in Q2, Greenberger lowered her comp assumptions and cut her price target on lululemon shares to $70 from $74. 3. Morgan Stanley analyst Meta Marshall downgraded Ciena (CIEN) to Equal Weight from Overweight, saying that while the company can likely outgrow the market over the next couple of years, its industry remains intensely competitive and growth is slowing in the long haul market, leaving little room for multiple expansion. Marshall maintains a $23 price target on Ciena shares. 4. Smith & Wesson (SWHC) downgraded to Hold from Buy at Craig-Hallum by analyst Steven Dyer, as he thinks the current environment is "as good as it gets" for firearms demand. Based on past cycles, Dyer contends that November's election and activity right after that will likely mark the top of the current firearms cycle and the stock will react as comps become more difficult. 5. STMicroelectronics (STM) downgraded to Underperform from Neutral at BofA/Merrill, with the firm saying structural pressures will drive declining revenue from Q3 of 2017 and beyond. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CMA Comerica
$49.20

-0.01 (-0.02%)

09/16/16
09/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) coverage assumed with an Outperform from Neutral at Credit Suisse with analyst Edward Kelly saying he is encouraged by Wal-Mart's return to traffic growth against a deteriorating staples retail environment and its aggressive U.S. investments to solidify its position in an evolving industry. 2. Clorox (CLX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Comerica (CMA) upgraded to Conviction Buy from Neutral at Goldman with analyst Ryan Nash saying he sees upside to Comerica's current recently announced strategic plan to improve pre-tax returns by $230M. 4. Hormel Foods (HRL) upgraded to Buy from Hold at Edward Jones. 5. Micron (MU) upgraded to Buy from Neutral at Cleveland Research with analyst Kevin Rottinghaus saying Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
WEDB
10/06/16
INITIATION
Target $29
WEDB
Neutral
Comerica initiated with a Neutral at Wedbush
Wedbush analyst Peter Winter initiated Comerica with a Neutral and a $29 price target.
09/16/16
GSCO
09/16/16
UPGRADE
GSCO
Conviction Buy
Comerica upgraded to Conviction Buy from Neutral at Goldman
Goldman analyst Ryan Nash upgraded Comerica to Conviction Buy and increased its price target to $52 from $49. Nash sees upside to Comerica's current recently announced strategic plan to improve pre-tax returns by $230M. He expects additional revenue and expense steps to be announced during Q3 earnings that could add to the current momentum of the stock. Additionally, management notes all options are open, including M&A, which could provide downside protection to shares, the analyst wrote.
07/20/16
RBCM
07/20/16
NO CHANGE
RBCM
Comerica reported 'good' results, says RBC Capital
RBC Capital believes that Comerica reported "good" results, driven by reduced energy credit costs and good core fundamental trends. The firm thinks the company's GEAR Up initiative can significantly increase its earnings growth in 2017 and beyond. RBC raised its price target on the shares to $49 from $46 and keeps an Outperform rating.

TODAY'S FREE FLY STORIES

FENG

Phoenix New Media

$2.68

-0.07 (-2.55%)

08:12
06/23/17
06/23
08:12
06/23/17
08:12
Hot Stocks
Phoenix New Media announces receipt of SAPPRFT notice »

Phoenix New Media…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

08:11
06/23/17
06/23
08:11
06/23/17
08:11
Recommendations
Bed Bath & Beyond analyst commentary  »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

HAIN

Hain Celestial

$32.66

-0.5 (-1.51%)

08:11
06/23/17
06/23
08:11
06/23/17
08:11
Conference/Events
Hain Celestial management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

SYRS

Syros Pharmaceuticals

$16.86

-0.32 (-1.86%)

08:09
06/23/17
06/23
08:09
06/23/17
08:09
Hot Stocks
Syros Pharmaceuticals presents preclinical data on SY-1425 »

Syros Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBRY

BlackBerry

$11.06

0.41 (3.85%)

08:09
06/23/17
06/23
08:09
06/23/17
08:09
Hot Stocks
BlackBerry says won central bank of France as new customer »

Says cyber security…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

EA

Electronic Arts

$112.62

-0.55 (-0.49%)

08:07
06/23/17
06/23
08:07
06/23/17
08:07
Recommendations
Electronic Arts analyst commentary  »

Electronic Arts price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$126.23

2.65 (2.14%)

08:05
06/23/17
06/23
08:05
06/23/17
08:05
Hot Stocks
Alexion announces positive CHMP opinion for Soliris »

Alexion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

ALGN

Align Technology

$149.69

0.27 (0.18%)

08:04
06/23/17
06/23
08:04
06/23/17
08:04
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

TRMK

Trustmark

$31.67

-0.53 (-1.65%)

08:04
06/23/17
06/23
08:04
06/23/17
08:04
Downgrade
Trustmark rating change  »

Trustmark downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

AVEO Oncology

$0.73

0.0281 (4.02%)

08:03
06/23/17
06/23
08:03
06/23/17
08:03
Hot Stocks
AVEO Oncology reports positive CHMP opinion for tivozanib as RCC treatment »

AVEO Oncolog announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$170.68

0.5 (0.29%)

, HUM

Humana

$237.00

0.79 (0.33%)

08:03
06/23/17
06/23
08:03
06/23/17
08:03
Recommendations
Cigna, Humana, Aetna, WellCare, Anthem, Health Net, Centene, Molina Healthcare, UnitedHealth analyst commentary  »

Jefferies says healthcare…

CI

Cigna

$170.68

0.5 (0.29%)

HUM

Humana

$237.00

0.79 (0.33%)

AET

Aetna

$152.98

0.88 (0.58%)

WCG

WellCare

$183.60

6.06 (3.41%)

ANTM

Anthem

$193.36

1.29 (0.67%)

HNT

Health Net

CNC

Centene

$83.00

2.88 (3.59%)

MOH

Molina Healthcare

$71.31

1.58 (2.27%)

UNH

UnitedHealth

$186.50

1.58 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

ZAYO

Zayo Group

$31.27

-0.54 (-1.70%)

08:03
06/23/17
06/23
08:03
06/23/17
08:03
Hot Stocks
Zayo Group selected by global webscale company for wavelength solution »

A global webscale company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSM

Williams-Sonoma

$47.18

0.48 (1.03%)

08:02
06/23/17
06/23
08:02
06/23/17
08:02
Hot Stocks
Williams-Sonoma to open expansive dual concept store in Seattle »

Williams Sonoma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRFT

Perficient

$17.55

0.15 (0.86%)

08:01
06/23/17
06/23
08:01
06/23/17
08:01
Hot Stocks
Perficient acquires Clarity Consulting in accretive deal »

Perficient announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

NSAT

Norsat

08:01
06/23/17
06/23
08:01
06/23/17
08:01
Hot Stocks
Norsat shareholders approve plan of arrangement with Hytera Communications »

Norsat announced that at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATB

Catabasis Pharmaceuticals

$1.30

-0.01 (-0.76%)

08:00
06/23/17
06/23
08:00
06/23/17
08:00
Hot Stocks
Catabasis Pharmaceuticals to present results from MoveDMD trial at PPMD »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$7.80

0.29 (3.86%)

08:00
06/23/17
06/23
08:00
06/23/17
08:00
Options
Pandora call buyer realizes 8% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BIIB

Biogen

$280.57

1.97 (0.71%)

, SSNLF

Samsung

08:00
06/23/17
06/23
08:00
06/23/17
08:00
Hot Stocks
Biogen's IMRALDI granted positive opinion by CHMP »

The Committee for…

BIIB

Biogen

$280.57

1.97 (0.71%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

08:00
06/23/17
06/23
08:00
06/23/17
08:00
General news
N.Y. FX Outlook: The dollar looks likely to remain on a neutral footing »

N.Y. FX Outlook: The…

FIT

Fitbit

$5.09

0.1 (2.00%)

07:59
06/23/17
06/23
07:59
06/23/17
07:59
Recommendations
Fitbit analyst commentary  »

Fitbit reorganization of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$32.66

-0.5 (-1.51%)

07:59
06/23/17
06/23
07:59
06/23/17
07:59
Technical Analysis
Technical View: Hain Celestial near 52-week low in pre-market, analyst actions »

The stock is down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

MEI

Methode Electronics

$40.10

1.45 (3.75%)

07:54
06/23/17
06/23
07:54
06/23/17
07:54
Recommendations
Methode Electronics analyst commentary  »

Baird remains a buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HNHPF

Hon Hai Precision

, TOSYY

Toshiba, also use TOSBF

$17.39

0.085 (0.49%)

07:53
06/23/17
06/23
07:53
06/23/17
07:53
Periodicals
Foxconn's Gou still sees 50% chance of landing Toshiba chip unit, DigiTimes says »

Foxconn (HNHPF) Chairman…

HNHPF

Hon Hai Precision

TOSYY

Toshiba, also use TOSBF

$17.39

0.085 (0.49%)

TOSBF

Toshiba, also use TOSYY

$2.88

-0.01 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$35.36

0.48 (1.38%)

07:53
06/23/17
06/23
07:53
06/23/17
07:53
Hot Stocks
AstraZeneca announces positive CHMP opinion for Faslodex »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

V

Visa

$93.95

-0.59 (-0.62%)

07:52
06/23/17
06/23
07:52
06/23/17
07:52
Recommendations
Visa analyst commentary  »

Visa a good idea for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.